This post may refer to COVID-19
To access official information about the coronavirus, access CDC - Centers for Disease Control and Prevention.
www.goodnewsnetwork.org
Exciting Study Results Say COVID-19 Vaccine Was Effective and Well-Tolerated for Its 45 Adult Participants
The study results released this week in the New England Journal of Medicine found that the mRNA-1273 developed by Moderna was safe and effective in adults.
Health
It has now been four months since this investigational vaccine designed to protect against COVID-19 was tested on humans for the first time in the US—and its recently-released trial results are inspiring hope amongst the healthcare community.
The interim report of the trials details how the vaccine, mRNA-1273, was not only shown to be well-tolerated in healthy adult participants, but it also prompted neutralizing antibody activity against the novel coronavirus.
The experimental vaccine is being co-developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and at Massachusetts-based biopharmaceutical company Moderna, Inc.